Education
About Us
Working with TipRanks
Follow Us
Sol-Gel Tech (SLGL)
:SLGL
SLGL Stock Chart & Stats
Day’s Range― - ―
52-Week Range$4.00 - $52.26
Previous CloseN/A
Volume503.92K
Average Volume (3M)21.27K
Market Cap
$110.46M
Enterprise Value-$2.49M
Total Cash (Recent Filing)$30.47M
Total Debt (Recent Filing)$1.39M
Price to Earnings (P/E)―
Beta1.44
Next Earnings
Nov 06, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)4.17
Shares Outstanding2,785,762
10 Day Avg. Volume18,647
30 Day Avg. Volume21,275
Financial Highlights & Ratios
PEG Ratio0.39
Price to Book (P/B)8.98
Price to Sales (P/S)22.45
P/FCF Ratio-18.65
Enterprise Value/Market Cap-0.02
Enterprise Value/Revenue-0.38
Enterprise Value/Gross Profit0.25
Enterprise Value/Ebitda0.15
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Sol-Gel Technologies News
SLGL FAQ
What was Sol-Gel Tech’s price range in the past 12 months?
Sol-Gel Tech lowest stock price was $4.00 and its highest was $52.26 in the past 12 months.
What is Sol-Gel Tech’s market cap?
Sol-Gel Tech’s market cap is $110.46M.
When is Sol-Gel Tech’s upcoming earnings report date?
Sol-Gel Tech’s upcoming earnings report date is Nov 06, 2025 which is in 25 days.
How were Sol-Gel Tech’s earnings last quarter?
Sol-Gel Tech released its earnings results on Aug 15, 2025. The company reported $4.17 earnings per share for the quarter, beating the consensus estimate of N/A by $4.17.
Is Sol-Gel Tech overvalued?
According to Wall Street analysts Sol-Gel Tech’s price is currently Overvalued.
Does Sol-Gel Tech pay dividends?
Sol-Gel Tech does not currently pay dividends.
What is Sol-Gel Tech’s EPS estimate?
Sol-Gel Tech’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Sol-Gel Tech have?
Sol-Gel Tech has 2,785,762 shares outstanding.
What happened to Sol-Gel Tech’s price movement after its last earnings report?
Sol-Gel Tech reported an EPS of $4.17 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 1.246%.
Which hedge fund is a major shareholder of Sol-Gel Tech?
Currently, no hedge funds are holding shares in SLGL
Sol-Gel Technologies Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Crowd Wisdom
Neutral
Last 7 Days ▲ 4.2%
Last 30 Days ▼ 4.7%
Last 30 Days ▼ 4.7%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
492.73%
12-Months-Change
Fundamentals
Return on Equity
-10.21%
Trailing 12-Months
Asset Growth
-6.42%
Trailing 12-Months
Company Description
Sol-Gel Tech
Sol-Gel Technologies Ltd., a clinical stage specialty pharmaceutical company, focuses on developing and commercializing topical dermatological drug products based on its proprietary microencapsulation delivery system in Israel. The company's lead product candidates include Twyneo, a novel, once-daily, non-antibiotic topical cream which has completed Phase III clinical trials for the treatment of acne vulgaris; Epsolay, a once-daily topical cream that has completed Phase III clinical trials for the treatment of papulopustular rosacea; SGT-210, which is in Phase I clinical trial for the treatment of palmoplantar keratoderma; and Erlotinib, Tapinarof, and roflumilast to treat psoriasis and other medical conditions. It is also involved in the development of generic topical dermatological drug products. The company has collaboration with Perrigo. Sol-Gel Technologies Ltd. was incorporated in 1997 and is headquartered in Ness Ziona, Israel.
Technical Analysis
Ownership Overview
―
Insiders
0.05% Mutual Funds
8.87% Other Institutional Investors
91.08% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---